|
| 36266539 | Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers. | Hypertens Res | 2023 |
| 37409573 | Bexagliflozin as an adjunct to metformin for the treatment of type 2 diabetes in adults: A 24-week, randomized, double-blind, placebo-controlled trial. | Diabetes Obes Metab | 2023 |
| 36790596 | Results From a Randomized, Open-Label, Crossover Study Evaluating the Effect of the Aldosterone Synthase Inhibitor Baxdrostat on the Pharmacokinetics of Metformin in Healthy Human Subjects. | Am J Cardiovasc Drugs | 2023 |
| 36342143 | Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension. | N Engl J Med | 2023 |
| 36178197 | A 96-week, double-blind, randomized controlled trial comparing bexagliflozin to glimepiride as an adjunct to metformin for the treatment of type 2 diabetes in adults. | Diabetes Obes Metab | 2023 |
| 35285245 | Correction for Jeyaseelan et al., "Distinct Roles of Pattern Recognition Receptors CD14 and Toll-Like Receptor 4 in Acute Lung Injury". | Infect Immun | 2022 |
| 34367681 | An overview of the process, progress, and outcomes of a National Center for Accelerated Innovation: The Boston Biomedical Innovation Center Experience. | J Clin Transl Sci | 2021 |
| 31749238 | A 12-week, randomized, double-blind, placebo-controlled, four-arm dose-finding phase 2 study evaluating bexagliflozin as monotherapy for adults with type 2 diabetes. | Diabetes Obes Metab | 2020 |
| 31161692 | A 24-week, randomized, double-blind, active-controlled clinical trial comparing bexagliflozin with sitagliptin as an adjunct to metformin for the treatment of type 2 diabetes in adults. | Diabetes Obes Metab | 2019 |
| 31644864 | Case 22-2019: A 65-Year-Old Woman with Myopathy. Reply. | N Engl J Med | 2019 |
| 31297965 | A 96-week, multinational, randomized, double-blind, parallel-group, clinical trial evaluating the safety and effectiveness of bexagliflozin as a monotherapy for adults with type 2 diabetes. | Diabetes Obes Metab | 2019 |
| 31314973 | Case 22-2019: A 65-Year-Old Woman with Weakness, Dark Urine, and Dysphagia. | N Engl J Med | 2019 |
| 31101403 | Safety and Effectiveness of Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3a/3b CKD. | Am J Kidney Dis | 2019 |
| 29767459 | Long-term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin-converting enzymes/angiotensin receptor blockers: results from AMETHYST-DN. | ESC Heart Fail | 2018 |
| 28775338 | NIH Centers for Accelerated Innovations Program: principles, practices, successes and challenges. | Nat Rev Drug Discov | 2017 |
| 28267733 | US immigration order strikes against biotech. | Nat Biotechnol | 2017 |
| 25632026 | Exome sequencing in suspected monogenic dyslipidemias. | Circ Cardiovasc Genet | 2015 |
| 26376130 | Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia. | Kidney Int | 2015 |
| 26172895 | Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial. | JAMA | 2015 |
| 25882488 | Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association. | Circulation | 2015 |
| 24293640 | Endogenous β-glucocerebrosidase activity in Abca12â»/â»epidermis elevates ceramide levels after topical lipid application but does not restore barrier function. | J Lipid Res | 2014 |
| 25734176 | High-density lipoprotein-mediated cholesterol efflux capacity is improved by treatment with antiretroviral therapy in acute human immunodeficiency virus infection. | Open Forum Infect Dis | 2014 |
| 22116191 | The Creating an Optimal Warfarin Nomogram (CROWN) Study. | Thromb Haemost | 2012 |
| 23012897 | Safety and dosing of bevacizumab (avastin) for the treatment of recurrent respiratory papillomatosis. | Ann Otol Rhinol Laryngol | 2012 |
| 21441830 | The path from bench to bedside: considerations before starting the journey. | J Investig Med | 2011 |
| 22097147 | Local injection of bevacizumab (Avastin) and angiolytic KTP laser treatment of recurrent respiratory papillomatosis of the vocal folds: a prospective study. | Ann Otol Rhinol Laryngol | 2011 |
| 21860089 | Wild type and Tangier disease ABCA1 mutants modulate cellular amyloid-β production independent of cholesterol efflux activity. | J Alzheimers Dis | 2011 |
| 18948635 | Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. | Arterioscler Thromb Vasc Biol | 2009 |
| 18484747 | SPTLC1 binds ABCA1 to negatively regulate trafficking and cholesterol efflux activity of the transporter. | Biochemistry | 2008 |
| 19430537 | Targeting Innate Immunity for CV Benefit. | Drug Discov Today Ther Strateg | 2008 |
| 18957418 | ABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of ceramide linoleic esters. | J Biol Chem | 2008 |
| 17142808 | ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol. | J Lipid Res | 2007 |
| 17303779 | Genetic etiology of isolated low HDL syndrome: incidence and heterogeneity of efflux defects. | Arterioscler Thromb Vasc Biol | 2007 |
| 17196452 | Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol. | Am J Cardiol | 2007 |
| 16449790 | Statins, cholesterol, and the prevention of coronary heart disease. | FASEB J | 2006 |
| 16728653 | Scavenger receptors in atherosclerosis: beyond lipid uptake. | Arterioscler Thromb Vasc Biol | 2006 |
| 16823376 | A sequence-oriented comparison of gene expression measurements across different hybridization-based technologies. | Nat Biotechnol | 2006 |
| 15731076 | Distinct roles of pattern recognition receptors CD14 and Toll-like receptor 4 in acute lung injury. | Infect Immun | 2005 |
| 30795382 | Spatial Analysis of Almond Leaf Scorch Disease in the San Joaquin Valley of California: Factors Affecting Pathogen Distribution and Spread. | Plant Dis | 2005 |
| 16646848 | Generalized rank tests for replicated microarray data. | Stat Appl Genet Mol Biol | 2005 |
| 16192269 | Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of beta1-syntrophin in cholesterol efflux. | J Biol Chem | 2005 |
| 16043658 | Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment. | Circulation | 2005 |
| 16078385 | Nonparametric methods for microarray data based on exchangeability and borrowed power. | J Biopharm Stat | 2005 |
| 16026120 | Atherosclerosis and innate immune signaling. | Ann Med | 2005 |
| 16075060 | Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. | J Clin Invest | 2005 |
| 15550377 | Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels. | J Biol Chem | 2005 |
| 15781429 | Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia. | Eur Heart J | 2005 |
| 14617740 | ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. | J Lipid Res | 2004 |
| 15567863 | Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis. | Science | 2004 |
| 15367722 | The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades. | Physiol Genomics | 2004 |